Disclosures
Freiwillige Akademische, DeQuervain, Stroke
HEART, STROKE
Dr Polymeris: funding from Swiss Academy of Medical Sciences (SAMS)/Bangerter-Rhyner-Foundation, Swiss Heart Foundation (SHF). Dr Siepen: funding from SAMS/Bangerter-Rhyner-Foundation. Dr Tsakiris: unrestricted research grants and lecture honoraria from Bayer Schweiz AG, Pfizer, Daiichi Sankyo, Takeda. Dr Sprigg: grants from the National Institute of Health Research. Dr Thilemann: travel grants from Bristol Myers Squibb (BMS)/Pfizer. Dr Wagner: funding by the Doc.Mobility instrument of the Swiss National Science Foundation (SNSF), Prof Dr med Karl und Rena Theiler-Haag Stiftung. Dr Traenka: research grants from SHF; personal research scholarships from the Novartis Foundation for biological and medical research, Freiwillige Akademische Gesellschaft Basel, Bangerter-Rhyner Foundation, and University of Basel; travel grants from Bayer. Dr Gensicke: research support from SNSF; advisory board honoraria from Daiichi Sankyo; funding for travel from BMS/Pfizer, and AbbVie. Dr De Marchis: support from SNSF (Nr.32003B_200573 and Nr.PBBEP3_139388); Spezialprogramm Nachwuchsförderung Klinische Forschung, University of Basel; Science Funds (Wissenschaftspool) of the University Hospital Basel; SHF; ProPatient Foundation Basel; Bangerter-Rhyner-Stiftung; Swisslife Jubiläumsstiftung for Medical Research; Swiss Neurological Society; Fondazione Dr. Ettore Balli; DeQuervain research grant; Thermo Fisher GmbH; Novartis grant; travel honoraria from Bayer, BMS/Pfizer; speaker honoraria from Bayer, Medtronic; consultant honoraria from Bayer, Novartis; member of the Steering Committee of PACIFIC Stroke (